NCT05312424View on ClinicalTrials.gov

Annatto-derived GG for Statin-associated Myopathy

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

95

Participants

Timeline

Start Date

July 15, 2022

Primary Completion Date

June 30, 2027

Study Completion Date

December 31, 2027

Conditions
Myopathy; Primary
Interventions
DIETARY_SUPPLEMENT

Placebo

300 mg olive oil

DIETARY_SUPPLEMENT

Low GG

150 mg GG

DIETARY_SUPPLEMENT

High GG

300 mg GG

Trial Locations (1)

79430

RECRUITING

Texas Tech University Health Sciences Center, Lubbock

All Listed Sponsors
lead

Texas Tech University Health Sciences Center

OTHER